Anlon Healthcare submits analyst meet intimation

18 Mar 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulation) read with part A of Schedule III of the Regulations, Anlon Healthcare has informed that the Punikumar Rasadia, Chairman and Managing Director of the Company will be interacting with the following Analyst(s)/ Investor(s) on Saturday, March 21, 2026 as per the details enclosed. 

The above information is a part of company’s filings submitted to BSE.

Anlon Healthcare Share Price

111.30 -4.70 (-4.05%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×